Alteration of PD-L1 (SP142) status after neoadjuvant chemotherapy and its clinical significance in triple-negative breast cancer.
Ji Won WooEun Kyung HanKoung Jin SuhSe Hyun KimJee Hyun KimSo Yeon Park
Published in: Breast cancer research and treatment (2024)
PD-L1 (SP142) status changes after NAC, mostly as a positive conversion. As PD-L1 (SP142) status can convey prognostic and predictive information, it needs to be tested before and after NAC.